Paper Details

  1. Home
  2. Paper Details

Tapinarof cream 1% once daily for the treatment of adults with mild to severe plaque psoriasis: A novel topical therapy targeting the aryl hydrocarbon receptor.

Author: ArmstrongApril W, McConahaJamie L

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This article discusses the treatment of plaque psoriasis, a chronic inflammatory skin disease. While existing therapies have limitations, a new topical treatment, tapinarof cream 1%, has been approved for adults. Tapinarof is a nonsteroidal, aryl hydrocarbon receptor agonist that demonstrated high rates of complete skin clearance in clinical trials. It has a durable effect, no rebound effects after cessation of therapy, and no contraindications or drug-drug interactions. Tapinarof cream addresses many of the limitations of current therapies and offers a well-tolerated, steroid-free option for patients with plaque psoriasis.
Paper Details　
Original Abstract of the Article :
Plaque psoriasis is a chronic, immunemediated skin disease characterized by scaly, erythematous, pruritic plaques. The effects of psoriasis are often debilitating and stigmatizing, significantly impacting patients' physical and psychological well-being and quality of life. Current guideline-recommen...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.18553/jmcp.2023.29.12-a.s1

データ提供：米国国立医学図書館（NLM）

Tapinarof Cream: A New Topical Therapy for Plaque Psoriasis

This review delves into the groundbreaking development of tapinarof cream, a novel topical therapy for plaque psoriasis. The authors highlight the limitations of existing treatments for this chronic skin condition and present a comprehensive overview of tapinarof cream's efficacy, safety, and tolerability based on clinical trial data.

The review demonstrates that tapinarof cream effectively treats plaque psoriasis, achieving high rates of complete skin clearance and providing durable effects. It is also well-tolerated and offers a steroid-free alternative to current treatment options, representing a significant advancement in the management of this debilitating condition. This discovery is like a resourceful desert traveler finding a new, reliable source of water to quench their thirst.

A Promising New Frontier in Psoriasis Treatment

The development of tapinarof cream represents a significant breakthrough in the treatment of plaque psoriasis. This novel topical therapy offers a safe and effective alternative to existing treatments, potentially improving the lives of millions suffering from this chronic skin condition. It's like a camel using its natural adaptations to survive in the harsh desert, providing a model for overcoming challenges.

Hope for a Brighter Future for Psoriasis Sufferers

This review provides a glimmer of hope for those struggling with plaque psoriasis. It's like a desert traveler finding a hidden oasis, offering a refuge from the scorching heat and arid landscape. The development of tapinarof cream signifies a new era in psoriasis treatment, bringing relief and improving quality of life for many.

Dr.Camel's Conclusion

Tapinarof cream represents a significant advancement in the treatment of plaque psoriasis. Its efficacy, safety, and tolerability make it a promising new therapeutic option for patients seeking relief from this chronic and debilitating condition.

Date :
  1. Date Completed 2023-12-07
  2. Date Revised 2023-12-07
Further Info :

Pubmed ID

38051146

DOI: Digital Object Identifier

10.18553/jmcp.2023.29.12-a.s1

Related Literature

Article Analysis
・Effects of tapinarof topical
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.